Analyst Ratings for Arch Therapeutics (ARTH) [Neutrals]
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/30/2023 | Dawson James | Jason Kolbert | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.60 (1.18) |
96.67% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/30/2023 | Dawson James | Jason Kolbert | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.60 (1.18) |
96.67% | Details |
